Dublin, Feb. 25, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/zmzmmz/artificial_tears) has announced the addition of the "Artificial Tears - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 68 companies including many key and niche players such as:
- Abbott Medical Optics Inc. (US)
- Allergan, Inc. (US)
- Akorn, Inc. (US)
- Bausch & Lomb Incorporated. (US)
- Johnson & Johnson (US)
- Novartis International AG (Switzerland)
- Alcon, Inc. (Switzerland)
- Santen Pharmaceuticals Co, Ltd. (Japan)
- Novagali Pharma S.A. (France)
Key Topics Covered:
1. Industry Overview
2. Noteworthy Market Trends
3. Dry Eye Syndrome
4. Product Overview
5. Product Launches/Approvals/ Introductions
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
Total Companies Profiled: 68 (including Divisions/Subsidiaries 74)
- The United States (25)
- Canada (3)
- Japan (4)
- Europe (22)
- - France (3)
- - Germany (3)
- - The United Kingdom (5)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (17)
- Africa (2)
- Middle-East (1)
For more information visit http://www.researchandmarkets.com/research/zmzmmz/artificial_tears
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Optical


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



